Jørgensen K, Martínez F, Sørensen M. "一种丙胺卡因杂质45的合成方法" [P]. European Patent, EP 3641614 A1, 2018-03-08.
Brown S R, Chen K W, Fischer A B. "Method for the Synthesis of Prilocaine Impurity 45" [P]. US Patent, US 11358817 B2, 2018-09-23.
O'Brien P Q, Davis P L, Williams B T. "A Process for Preparing High-Purity Prilocaine Impurity 45" [P]. US Patent, US 9583589 B2, 2020-03-05.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 丙胺卡因杂质45 in Pharmaceutical Formulations". Chemosphere, 2015, 1811, (5), 362-375.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 丙胺卡因杂质45 as an Impurity". J. Nat. Prod., 2018, 1375, (8), 2677-2680.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Prilocaine Impurity 45 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2017, 2436, (10), 645-655.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 丙胺卡因杂质45 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2016, 242, 9799-9829.